Sun Pharmaceutical Industries informs about press release

07 Apr 2025 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma introducing a novel class of drug, Fexuclue®(Fexuprazan) in India for the treatment of Erosive Esophagitis, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1719.20 -18.30 (-1.05%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×